AT179013B - Verfahren zur Herstellung von als Plasmaersatzmittel bestimmten Injektionslösungen - Google Patents

Verfahren zur Herstellung von als Plasmaersatzmittel bestimmten Injektionslösungen

Info

Publication number
AT179013B
AT179013B AT179013DA AT179013B AT 179013 B AT179013 B AT 179013B AT 179013D A AT179013D A AT 179013DA AT 179013 B AT179013 B AT 179013B
Authority
AT
Austria
Prior art keywords
preparation
injection solutions
solutions intended
plasma substitutes
substitutes
Prior art date
Application number
Other languages
English (en)
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Application granted granted Critical
Publication of AT179013B publication Critical patent/AT179013B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02—Dextran; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
AT179013D 1948-07-15 1948-07-15 Verfahren zur Herstellung von als Plasmaersatzmittel bestimmten Injektionslösungen AT179013B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT179013T 1948-07-15

Publications (1)

Publication Number Publication Date
AT179013B true AT179013B (de) 1954-07-10

Family

ID=3660097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT179013D AT179013B (de) 1948-07-15 1948-07-15 Verfahren zur Herstellung von als Plasmaersatzmittel bestimmten Injektionslösungen

Country Status (1)

Country Link
AT (1) AT179013B (de)

Similar Documents

Publication Publication Date Title
AT334335B (de) Verfahren zur herstellung von 1-phenyl-2-aminoathanolen-(1)
AT179013B (de) Verfahren zur Herstellung von als Plasmaersatzmittel bestimmten Injektionslösungen
CH280198A (de) Verfahren zur Herstellung von Kopolymeren.
CH283770A (de) Verfahren zur Herstellung von Waschmitteln.
AT172334B (de) Verfahren zur Herstellung von N-Dialkylaminoalkylphenthiazinen
AT164803B (de) Verfahren zur Herstellung von Düngemitteln
AT182196B (de) Verfahren zur Herstellung von Injektionslösungen
AT172060B (de) Verfahren zur Herstellung von Phenoplast-Preßstoffmassen
AT181530B (de) Verfahren zur Herstellung von Schuhwerk
AT193400B (de) Verfahren zur Herstellung von Phenolen
AT181692B (de) Verfahren zur Herstellung von zur Injektion bestimmten Präparaten
AT179651B (de) Verfahren zur Herstellung von Formkörpern
AT178459B (de) Verfahren zur Herstellung von Polyvinylidencyanid
AT176377B (de) Verfahren zur Herstellung von Farbstoffmischungen
CH281278A (de) Verfahren zur Herstellung von 1-Phenyl-2-aminopropan.
AT170271B (de) Verfahren zur Herstellung von bindemittelfreien Formkörpern aus Fasermaterial
AT173422B (de) Verfahren zur Herstellung von zweiteiligen Strümpfen
AT172493B (de) Verfahren zur Herstellung von Hartfaserplatten
AT167706B (de) Verfahren zur Herstellung von druckfesten Bauelementen
AT170853B (de) Verfahren zur Herstellung von Methanol
CH276856A (de) Verfahren zur Herstellung von 2-Carboxyäthylmercapto-benzol-stibinsäure.
CH282221A (de) Verfahren zur Herstellung von Stilben-4-arsensäure.
AT195426B (de) Verfahren zur Herstellung von N<4>-Dicarboxyacylsulfanilamiden
AT183871B (de) Verfahren zur Herstellung von wässerigen Lactoflavin enthaltenden Lösungen
AT171981B (de) Verfahren zur Herstellung von lagerbeständigen Boroformiatpräparaten